Effects of Combination Hydroxyurea and Chronic Red Blood Cell Transfusion Therapy on the Immune Parameters of Patients with Sickle Cell Disease

被引:0
|
作者
Oldham, Mahogany [1 ]
Sani, Gelina [2 ]
Margulies, Stefanie [2 ]
Webb, Jennifer [2 ]
Nickel, Robert Sheppard [2 ]
Abraham, Allistair [2 ]
机构
[1] Univ Toledo, Coll Med, 2801 W Bancroft St, Toledo, OH 43606 USA
[2] Childrens Natl Hlth Syst, Washington, DC USA
关键词
D O I
10.1182/blood-2019-126180
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
4840
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Indications for red cell transfusion in sickle cell disease
    Ohene-Frempong, K
    SEMINARS IN HEMATOLOGY, 2001, 38 (01) : 5 - 13
  • [42] Barriers and Facilitators to Chronic Red Cell Transfusion Therapy in Pediatric Sickle Cell Anemia
    Schlenz, Alyssa M.
    Phillips, Shannon M.
    Mueller, Martina
    Melvin, Cathy L.
    Adams, Robert J.
    Kanter, Julie
    JOURNAL OF PEDIATRIC HEMATOLOGY-ONCOLOGY NURSING, 2022, 39 (04): : 209 - 220
  • [43] Red blood cell alloimmunisation in patients with sickle cell disease
    Volt, Fernanda
    LANCET HAEMATOLOGY, 2017, 4 (11): : E506 - E507
  • [44] Red blood cell alloimmunization in sickle cell disease patients
    Castilho, SL
    Amorim, LM
    Lobo, CL
    TRANSFUSION, 1999, 39 (10) : 50S - 50S
  • [45] Hydroxyurea therapy for sickle cell disease in Britain
    Olujohungbe, A
    Cinkotai, KI
    Yardumian, A
    BRITISH MEDICAL JOURNAL, 1998, 316 (7146): : 1689 - 1689
  • [46] Blood transfusion in sickle cell disease
    Davies, SC
    RobertsHarewood, M
    BLOOD REVIEWS, 1997, 11 (02) : 57 - 71
  • [47] Effects of prophylactic red blood cell (RBC) transfusion with extended antigen matching on alloimmunization in patients with Sickle Cell Disease (SCD)
    Leal, Ianca
    dos Santos, Tamires Delfino
    Gilli, Simone
    Castilho, Lilian
    TRANSFUSION AND APHERESIS SCIENCE, 2023, 62 (06)
  • [48] BLOOD TRANSFUSION IN SICKLE CELL DISEASE
    Marouf, Rajaa
    HEMOGLOBIN, 2011, 35 (5-6) : 495 - 502
  • [49] The case for and against initiating either hydroxyurea therapy, blood transfusion therapy or hematopoietic stem cell transplant in asymptomatic children with sickle cell disease
    Kassim, Adetola A.
    DeBaun, Michael R.
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (03) : 325 - 336
  • [50] Reticulocyte parameters and hemoglobin F production in sickle cell disease patients undergoing hydroxyurea therapy
    Borba, R
    Lima, CSP
    Grotto, HZW
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2003, 17 (02) : 66 - 72